Eight patients were excluded after enrollment, 4 because of renal failure, 1 because of recurrent hypoglycemia while taking metformin alone, 1 because of hyperglycemia requiring insulin therapy, and 2 because of terminal illness. The gene discussed is INS; the disease is Hypoglycemia.